Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients.
Acromegaly
Insulin-like growth factor-1
Magnetic resonance imaging
Masseter
Skeletal muscle
Temporal
Journal
Pituitary
ISSN: 1573-7403
Titre abrégé: Pituitary
Pays: United States
ID NLM: 9814578
Informations de publication
Date de publication:
05 Jul 2024
05 Jul 2024
Historique:
accepted:
23
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
5
7
2024
Statut:
aheadofprint
Résumé
The impact of GH/IGF-1 levels on skeletal muscle in acromegaly is still controversial. Temporal (TMT) and masseter muscle (MMT) thickness has been recently demonstrated as a reliable measure of muscle mass. We aimed to investigate the relationship between TMT, MMT and clinical/biochemical characteristics in patients with acromegaly. Single center retrospective longitudinal study including 69 patients with at least one available brain/sella turcica MRI and matched clinical data. TMT, MMT, and muscle fatty infiltration (modified Goutallier score) were evaluated in all patients at baseline (first available MRI) and over time (182 MRIs analyzed). At baseline, both TMT and MMT were higher in males than females (p = 0.001 and p = 0.016, respectively). TMT and MMT were positively associated (β 0.508, p < 0.001), and they were positively correlated with IGF-1 xULN (TMT, p = 0.047; MMT, p = 0.001). MMT had a positive correlation with patients' weight (p = 0.015) and height (p = 0.006). No correlation was found between TMT, MMT and the presence of hypogonadism. Considering all available MRIs, sex and IGF-1 xULN were significant determinants of TMT and MMT at multivariable analysis (female sex: β -0.345/-0.426, p < 0.001; IGF-1 xULN: β 0.257/0.328, p < 0.001). At longitudinal evaluation, uncontrolled patients at baseline showed a significant reduction of MMT over time (p = 0.044). Remarkable fatty infiltration was observed in 34-37% of MRIs; age was the main determinant (temporal muscle: OR 1.665; p = 0.013; masseter muscle: OR 1.793; p = 0.009). Male patients with higher IGF-1 values have thicker temporal and masseter muscles, suggesting that sex and IGF-1 have a significant impact on muscle mass in acromegaly.
Identifiants
pubmed: 38967765
doi: 10.1007/s11102-024-01422-y
pii: 10.1007/s11102-024-01422-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(22)00244-3
doi: 10.1016/S2213-8587(22)00244-3
pubmed: 36209758
Crisafulli S, Luxi N, Sultana J, Fontana A, Spagnolo F, Giuffrida G, Ferrau F, Gianfrilli D, Cozzolino A, De Martino C, Gatto M, Barone-Adesi F, Cannavo F, S., and, Trifiro G (2021) Global epidemiology of acromegaly: a systematic review and meta-analysis. Eur J Endocrinol. https://doi.org/10.1530/EJE-21-0216
doi: 10.1530/EJE-21-0216
pubmed: 34061771
Arlien-Soborg MC, Dal J, Madsen MA, Hogild ML, Hjelholt AJ, Pedersen SB, Moller N, Jessen N, Jorgensen JOL (2022) Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly. https://doi.org/10.1016/j.ebiom.2021.103763 . EBioMedicine
Freda PU, Shen W, Heymsfield SB, Reyes-Vidal CM, Geer EB, Bruce JN, Gallagher D (2008) Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2007-2780
doi: 10.1210/jc.2007-2780
pubmed: 18957506
pmcid: 2626443
Mastaglia FL, Barwich DD, Hall R (1970) Myopathy in Acromegaly. Lancet. https://doi.org/10.1016/s0140-6736(70)92072-6
doi: 10.1016/s0140-6736(70)92072-6
pubmed: 4097284
Nagulesparen M, Trickey R, Davies MJ, Jenkins JS (1976) Muscle changes in acromegaly. Br Med J. https://doi.org/10.1136/bmj.2.6041.914
doi: 10.1136/bmj.2.6041.914
pubmed: 974660
pmcid: 1688457
Fuchtbauer L, Olsson DS, Bengtsson BA, Norrman LL, Sunnerhagen KS, Johannsson G (2017) Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up. Eur J Endocrinol. https://doi.org/10.1530/EJE-17-0120
doi: 10.1530/EJE-17-0120
pubmed: 28566445
Miller A, Doll H, David J, Wass J (2008) Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol. https://doi.org/10.1530/EJE-07-0838
doi: 10.1530/EJE-07-0838
pubmed: 18426816
Martel-Duguech L, Alonso-Perez J, Bascunana H, Diaz-Manera J, Llauger J, Nunez-Peralta C, Montesinos P, Webb SM, Valassi E (2021) Intramuscular fatty infiltration and physical function in controlled acromegaly. Eur J Endocrinol. https://doi.org/10.1530/EJE-21-0209
doi: 10.1530/EJE-21-0209
pubmed: 33950861
Reyes-Vidal CM, Mojahed H, Shen W, Jin Z, Arias-Mendoza F, Fernandez JC, Gallagher D, Bruce JN, Post KD, Freda PU (2015) Adipose tissue redistribution and ectopic lipid deposition in active Acromegaly and effects of Surgical Treatment. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-1917
doi: 10.1210/jc.2015-1917
pubmed: 26037515
pmcid: 4524994
Lopes AA, Albuquerque L, Fontes M, Rego D, Bandeira F (2022) Body composition in Acromegaly according to Disease Activity - Performance of Dual X-Ray Absorptiometry and Multifrequency Bioelectrical Impedance Analysis. Front Endocrinol (Lausanne). https://doi.org/10.3389/fendo.2022.866099
doi: 10.3389/fendo.2022.866099
pubmed: 35663315
Ozturk Gokce B, Gogus F, Bolayir B, Tecer D, Gokce O, Eroglu Altinova A, Toruner B, F., and, Akturk M (2020) The evaluation of the tendon and muscle changes of lower extremity in patients with acromegaly. Pituitary. https://doi.org/10.1007/s11102-020-01037-z
doi: 10.1007/s11102-020-01037-z
pubmed: 32200458
Reid TJ, Jin Z, Shen W, Reyes-Vidal CM, Fernandez JC, Bruce JN, Kostadinov J, Post KD, Freda PU (2015) IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition. Pituitary. https://doi.org/10.1007/s11102-015-0657-2
doi: 10.1007/s11102-015-0657-2
pubmed: 25907335
pmcid: 4619193
Kuker AP, Shen W, Jin Z, Singh S, Chen J, Bruce JN, Freda PU (2021) Body composition changes with long-term Pegvisomant Therapy of Acromegaly. J Endocr Soc. https://doi.org/10.1210/jendso/bvab004
doi: 10.1210/jendso/bvab004
pubmed: 33553983
pmcid: 7853172
Milioto A, Corica G, Nista F, Wildemberg LEA, Rossi F, Bignotti B, Gadelha MR, Ferone D, Tagliafico AS, Gatto F (2024) Skeletal muscle evaluation in patients with acromegaly. J Endocr Soc. https://doi.org/10.1210/jendso/bvae032
doi: 10.1210/jendso/bvae032
pubmed: 38434516
pmcid: 10907006
Ranganathan K, Terjimanian M, Lisiecki J, Rinkinen J, Mukkamala A, Brownley C, Buchman SR, Wang SC, Levi B (2014) Temporalis muscle morphomics: the psoas of the craniofacial skeleton. J Surg Res. https://doi.org/10.1016/j.jss.2013.07.059
doi: 10.1016/j.jss.2013.07.059
pubmed: 25201576
Furtner J, Berghoff AS, Albtoush OM, Woitek R, Asenbaum U, Prayer D, Widhalm G, Gatterbauer B, Dieckmann K, Birner P, Aretin B, Bartsch R, Zielinski CC, Schopf V, Preusser M (2017) Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases. Eur Radiol. https://doi.org/10.1007/s00330-016-4707-6
doi: 10.1007/s00330-016-4707-6
pubmed: 28275900
pmcid: 5544808
Furtner J, Berghoff AS, Schopf V, Reumann R, Pascher B, Woitek R, Asenbaum U, Pelster S, Leitner J, Widhalm G, Gatterbauer B, Dieckmann K, Holler C, Prayer D, Preusser M (2018) Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases. J Neurooncol. https://doi.org/10.1007/s11060-018-2948-8
doi: 10.1007/s11060-018-2948-8
pubmed: 30008154
pmcid: 6182383
Sadhwani N, Aggarwal A, Mishra A, Garg K (2022) Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis. Neurosurg Rev. https://doi.org/10.1007/s10143-022-01892-3
doi: 10.1007/s10143-022-01892-3
pubmed: 36350492
Campana C, Cocchiara F, Corica G, Nista F, Arvigo M, Amaru J, Rossi DC, Zona G, Ferone D, Gatto F (2021) Discordant GH and IGF-1 results in treated acromegaly: impact of GH Cutoffs and Mean values Assessment. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa859
doi: 10.1210/clinem/dgaa859
pubmed: 33236108
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord. https://doi.org/10.1007/s11154-020-09588-z
doi: 10.1007/s11154-020-09588-z
pubmed: 32914330
pmcid: 7538371
van Esdonk MJ, van Zutphen EJM, Roelfsema F, Pereira AM, van der Graaf PH, Biermasz NR, Stevens J, Burggraaf J (2018) How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review. Pituitary. https://doi.org/10.1007/s11102-018-0884-4
doi: 10.1007/s11102-018-0884-4
pubmed: 29605877
pmcid: 5942341
Nazzari E, Casabella A, Paolino S, Campana C, Corica G, Nista F, Milioto A, Tagliafico A, Albertelli M, Boschetti M, Bagnasco M, Cutolo M, Ferone D, Gatto F (2022) Trabecular bone score as a Reliable measure of lumbar spine bone microarchitecture in Acromegalic patients. J Clin Med. https://doi.org/10.3390/jcm11216374
doi: 10.3390/jcm11216374
pubmed: 36362602
pmcid: 9656167
Tagliafico AS, Ameri P, Bovio M, Puntoni M, Capaccio E, Murialdo G, Martinoli C (2010) Relationship between fatty degeneration of thigh muscles and vitamin D status in the elderly: a preliminary MRI study. AJR Am J Roentgenol. https://doi.org/10.2214/AJR.09.3130
doi: 10.2214/AJR.09.3130
pubmed: 20173152
Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, Guicheney P, Muntoni F, Merlini L (2002) Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). https://doi.org/10.1016/s0960-8966(02)00023-8 . Neuromuscul Disord
Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF (2008) Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol. https://doi.org/10.1007/s00330-008-1071-1
doi: 10.1007/s00330-008-1071-1
pubmed: 18648820
Yang YW, Ming Y, Zhou YW, Xia X, Jia SL, Zhao YL, Zhou LX, Cao Y, Ge ML (2023) Prognostic value of temporal muscle thickness, a novel radiographic marker of Sarcopenia, in patients with brain tumor: a systematic review and meta-analysis. Nutrition. https://doi.org/10.1016/j.nut.2023.112077
doi: 10.1016/j.nut.2023.112077
pubmed: 38185094
pmcid: 10200278
Leitner J, Pelster S, Schopf V, Berghoff AS, Woitek R, Asenbaum U, Nenning KH, Widhalm G, Kiesel B, Gatterbauer B, Dieckmann K, Birner P, Prayer D, Preusser M, Furtner J (2018) High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases. PLoS ONE. https://doi.org/10.1371/journal.pone.0207849
doi: 10.1371/journal.pone.0207849
pubmed: 30496307
pmcid: 6264824
Steindl A, Leitner J, Schwarz M, Nenning KH, Asenbaum U, Mayer S, Woitek R, Weber M, Schopf V, Berghoff AS, Berger T, Widhalm G, Prayer D, Preusser M, Furtner J (2020) Sarcopenia in neurological patients: standard values for temporal muscle thickness and muscle strength evaluation. J Clin Med. https://doi.org/10.3390/jcm9051272
doi: 10.3390/jcm9051272
pubmed: 32354003
pmcid: 7288067
Yang SM, Wu HW, Lin YH, Lai TJ, Lin MT (2023) Temporalis and masseter muscle thickness as predictors of post-stroke dysphagia after endovascular thrombectomy. Eur J Radiol. https://doi.org/10.1016/j.ejrad.2023.110939
doi: 10.1016/j.ejrad.2023.110939
pubmed: 38160541
van Heusden HC, Chargi N, Dankbaar JW, Smid EJ, de Bree R (2022) Masseter muscle parameters can function as an alternative for skeletal muscle mass assessments on cross-sectional imaging at lumbar or cervical vertebral levels. Quant Imaging Med Surg. https://doi.org/10.21037/qims-21-43
doi: 10.21037/qims-21-43
pubmed: 34993057
pmcid: 8666780
Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Consensus A (2023) Consensus on criteria for acromegaly diagnosis and remission. Pituitary. https://doi.org/10.1007/s11102-023-01360-1
doi: 10.1007/s11102-023-01360-1
pubmed: 38052967
pmcid: 10837242
Furtner J, Weller M, Weber M, Gorlia T, Nabors B, Reardon DA, Tonn JC, Stupp R, Preusser M, Group EBT (2022) Temporal muscle thickness as a prognostic marker in patients with newly diagnosed Glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071 – 22072 and CORE trials. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-21-1987
doi: 10.1158/1078-0432.CCR-21-1987
pubmed: 35998208
Bredella MA, Schorr M, Dichtel LE, Gerweck AV, Young BJ, Woodmansee WW, Swearingen B, Miller KK (2017) Body composition and ectopic lipid changes with biochemical control of Acromegaly. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2017-01210
doi: 10.1210/jc.2017-01210
pubmed: 28945897
pmcid: 6283448
Eroglu I, Iremli BG, Erkoc A, Idilman IS, Yuce D, Calik-Kutukcu E, Akata D, Erbas T (2023) Osteosarcopenia in Acromegaly: reduced muscle quality and increased vertebral fat deposition. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02114-3
doi: 10.1007/s40618-023-02114-3
pubmed: 37212954
Anderson DE, D’Agostino JM, Bruno AG, Demissie S, Kiel DP, Bouxsein ML (2013) Variations of CT-based trunk muscle attenuation by age, sex, and specific muscle. J Gerontol Biol Sci Med Sci. https://doi.org/10.1093/gerona/gls168
doi: 10.1093/gerona/gls168
Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH, Health A, Body (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. https://doi.org/10.3945/ajcn.2009.28047
doi: 10.3945/ajcn.2009.28047
pubmed: 19864405
pmcid: 2777469